Though the surge in Sierra Leone has received much of the attention, cases are also rising in two other countries in West Africa: Ghana and Liberia.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
Countries have made steady progress with outbreaks, but the virus is still a threat in multiple world regions.
The organizations recommend 4 actions to help prevent and manage any future outbreaks.
The WHO declared a public health emergency of international concern in July 2022 following the global spread of the virus.
Local adverse event rates were highest following intradermal vaccine administration.
Africa has had a 7.4% case increase, with 111 new infections in the most recent 2 weeks.
How much of a role HIV status has on mpox progression and as an independent risk factor for contracting the virus is unknown.
Nine mpox patients had new skin or mucosal lesions after completing the 14-day Tpoxx treatment course.
Activity is rising in the Western Pacific due to local transmission in Japan, South Korea, and China.
No transmission was noted in encampments, despite potential sharing of sleeping bags, clothes, and utensils.
Since the WHO's last update on March 30, countries have reported 206 new cases and 4 deaths, with all the new deaths in the Americas.
